Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STSP-0902 in Patients With Oligozoospermia and/or Asthenozoospermia
NCT07833943Phase 2Not yet recruiting
- Sponsor
- Staidson Biopharmaceutical
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of STSP-0902 in oligozoospermia, asthenozoospermia, sponsored by Staidson Biopharmaceutical. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
STSP-0902
03
Conditions
oligozoospermiaasthenozoospermia
Beyond the preview
Go deeper on NCT07833943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07833943.